Reynders McVeigh Capital Management’s Antares Pharma, Inc. ATRS Stock Holding History

Reynders McVeigh Capital Management’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-65,490	Closed	-$269K	–	237
2022 Q1	$269K	Hold	65,490	–	–	0.02%	204
2021 Q4	$234K	Sell	65,490 -169,000	-72%	-$591K	0.01%	217
2021 Q3	$854K	Sell	234,490 -25,000	-10%	-$101K	0.05%	117
2021 Q2	$1.13M	Sell	259,490 -100,510	-28%	-$409K	0.07%	102
2021 Q1	$1.48M	Buy	360,000 +106,068	+42%	+$460K	0.1%	92
2020 Q4	$1.01M	Buy	+253,932	New	+$822K	0.07%	100

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Reynders McVeigh Capital Management's ATRS Position: Q2 2022 in Review

Reynders McVeigh Capital Management sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 65,490 shares — an estimated $269K sold.

Reynders McVeigh Capital Management first reported a position in ATRS in Q4 2020 and held it in 6 quarters. The position peaked at $1.48M in Q1 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Reynders McVeigh Capital Management reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Reynders McVeigh Capital Management sold 65,490 Antares Pharma, Inc. shares in Q2 2022, an estimated $269K.
Reynders McVeigh Capital Management first reported a position in Antares Pharma, Inc. in Q4 2020 and held it in 6 quarters.
Reynders McVeigh Capital Management's Antares Pharma, Inc. position peaked at $1.48M in Q1 2021.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Reynders McVeigh Capital Management's 13F filing for Q2 2022, filed 5 Aug 2022.